Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

Nephrol Dial Transplant. 2001 Jan;16(1):193-5. doi: 10.1093/ndt/16.1.193.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Hepacivirus / drug effects
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Pilot Projects
  • RNA, Viral / blood
  • Recombinant Proteins
  • Renal Dialysis*
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use*
  • Safety

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Ribavirin